Taking a new approach toward tuberculosis therapy, a UCLA-led research team has devised a potential drug regimen that could cut the treatment time by up to 75 percent, while simultaneously reducing the risk that patients ...
Jan 25, 2017
0
6
(HealthDay)—For patients with long-standing poorly controlled type 2 diabetes mellitus (T2DM) on metformin plus a sulfonylurea, combination therapy with exenatide and pioglitazone is effective and safe, according to a study ...
Jan 23, 2017
0
0
Kenar D. Jhaveri, MD, and Richard Barnett, MD, Feinstein Institute for Medical Research scientists and Northwell Health Department of Internal Medicine nephrologists, published a Letter to the Editor in the prestigious New ...
Jan 18, 2017
0
9
A combination of a diabetes medication and an antihypertensive drug can effectively combat cancer cells. The team of researchers led by Prof. Michael Hall at the Biozentrum of the University of Basel has also reported that ...
Dec 27, 2016
0
2237
While many insights are gained into diseases and genetic disorders from rodent models, there is a pressing need to find models that can more accurately represent disease progression in the human body, such as non-human primates. ...
Dec 27, 2016
0
0
A team of UCLA bioengineers has demonstrated that its technology may go a long way toward overcoming the challenges of treatment for acute lymphoblastic leukemia, among the most common types of cancer in children, and has ...
Dec 13, 2016
0
2
Patient health records revealed two drug combinations that may reduce mortality rates in breast cancer patients, according to a study led by researchers at the Stanford University School of Medicine.
Dec 9, 2016
0
47
Women treated with a common chemotherapy drug combination have more young eggs in their ovaries afterwards, research has found.
Dec 6, 2016
0
139
Researchers from Columbia University Medical Center and NewYork-Presbyterian reported that 8 out of 12 patients with relapsed and/or chemotherapy refractory acute myeloid leukemia (AML) or other blood cancers responded to ...
Dec 5, 2016
0
0
The fixed combination of trifluridine/tipiracil (trade name: Lonsurf) has been approved since April 2016 for the treatment of metastatic colorectal cancer. The drugs are an option for adult patients with metastatic colorectal ...
Nov 22, 2016
0
0
